Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School
Go back to Axovant Licenses Investigational Gene Therapies for GM1 Gangliosidosis, Tay-Sachs and Sandhoff Diseases from University of Massachusetts Medical School| Axion Spatial Imaging Inc (NASDAQ: AXON) | Delayed: 452.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $452.06 | 52 Week High | $21.30 | |||
| Open | $452.06 | 52 Week Low | $8.86 | |||
| Day High | $452.06 | P/E | N/A | |||
| Day Low | $452.06 | EPS | $0.00 | |||
| Volume | 909 | |||||
